Saturday January 5, 2013
James Walsh
Reporter | Medical Technology
Phone: 612-673-7428
Email: jwalsh@startribune.com
James Walsh covers medical technology companies such as Medtronic and St. Jude and innovations.
Follow @stribjwalsh
Follow @stribjwalsh
Recent content from James Walsh
Medtronic heart device monitor speeds care
Medtronic's CareLink Express allows experts to "interrogate" implanted heart devices from afar, saving time and money.
Updated: August 14, 2012, - 09:49 PM
Med-tech manufacturer tackles own ideas
The trick, says Minnetronix CEO Rich Nazarian, is to create products that compliment customers' work.
Updated: August 12, 2012, - 11:16 AM
'No one knows why this has happened'
One Minnesota leader said a political climate that encourages suspicion could lead to such violence.
Updated: August 05, 2012, - 09:35 PM
Medtronic mentors in India reach back to Minnesota
A growing e-mail mentorship program connected Medtronic workers from half a world away to Buffalo High School.
Updated: August 03, 2012, - 10:12 PM
Boston Scientific reports quarterly loss
Inplantable cardiac devices and heart stents drove a sales decline.
Updated: July 26, 2012, - 08:13 PM
Keeping fit, staying well and changing lives
Two brothers went into business to help people with hemophilia, with physical therapy at the core of their work.
Updated: July 20, 2012, - 09:44 PM
St. Jude stock price slips as caution is perceived in second-quarter report
St. Jude reported gains in earnings per share, but declines in cardiac rhythm sales may have dampened analysts' enthusiasm.
Updated: July 18, 2012, - 09:24 PM
Will heart-lead woes hit St. Jude's bottom line?
The medical device company's own study shows a problem with wires working free of outer insulation, especially in larger leads.
Updated: July 16, 2012, - 08:44 PM
Coagulife bought by Cincinnati firm
Coagulife Pharmacy of Savage, founded in 2004 to address the treatment of hemophilia, has been acquired by competitor BioRx of Cincinnati. Terms were not disclosed.
Updated: July 09, 2012, - 08:21 PM
Defibrillator lead scare has St. Jude walking on eggshells
A one-day stock price drop in early June showed how skittish the market is around defibrillator leads, one analyst says.
Updated: July 05, 2012, - 09:25 PM
ADVERTISEMENT
- 'Person of interest' in cop slaying kills himself
- Hit on a miss: Vikings have learned lessons as season has progressed
- Costs sure to rise in Minneapolis water main break
- Assault case sidelines Hamline men's basketball
- Guardian charged after disabled Woodbury teen allegedly sold for sex
- Know the truth about the carrying of weapons
- 100-year-old Vikings fan now believes in miracles
- The Call: Vikings at Green Bay
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
inside the StarTribune
-
425 Portland Av. S.
Minneapolis, MN 55488
(612) 673-4000
- Company
- Subscriber Services
- Website
- Buy Ads
- Store
- Connect with Us
© 2013 StarTribune. All rights reserved.
StarTribune.com is powered by Limelight Networks
Newspaper Subscriptions
eEdition
RSS
Newsletters